Abstract
3/2024
vol. 30
Guidelines/recommendations
Guidelines of the Polish Society of Pediatric Endocrinology and Diabetology and Pediatric Section of Diabetes Poland on insulin therapy using hybrid closed-loop systems in children and adolescents with diabetes in Poland
- Department of Paediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Poland
- Department of Paediatrics, Institute of Medical Sciences, University of Opole, Poland
- Department of Paediatrics, Endocrinology, Diabetology with Cardiology Subdivision, Medical University of Bialystok, Poland
- Department of Paediatric Diabetology and Lifestyle Medicine, Medical University of Silesia in Katowice, Poland
- Department of Paediatrics, Diabetology and Endocrinology, Medical University of Gdansk, , Poland
- Department of Paediatric Diabetology and Paediatrics, Medical University of Warsaw, Poland
- Department of Paediatrics, Endocrinology, Diabetology and Metabolic Diseases, Medical University of Wroclaw, Poland
- Department of Paediatrics, Endocrinology, Diabetology, Metabolic Diseases and Developmental Cardiology, Pomeranian Medical University in Szczecin, Poland
Pediatr Endocrinol Diabetes Metab 2024; 30 (3): 132-147
Online publish date: 2024/10/18
Currently, hybrid closed loop (HCL) systems represent the most advantageous therapeutic option for people with diabetes requiring intensive insulin therapy. They make it possible to achieve optimal metabolic control of the disease in any age group while improving the quality of life of children and adolescents with diabetes and their families.
Therefore, we present recommendations for the use of HCL systems in children and adolescents focusing on systems currently available in Poland. These systems should be the first choice in terms of method of insulin therapy in the paediatric population. They can be implemented at any stage of diabetes management. These recommendations are based on scientific evidence and experts' experience. They include principles for the initiation, optimisation, and ongoing management of HCL therapy, as well as the required HCL-related education.
Therefore, we present recommendations for the use of HCL systems in children and adolescents focusing on systems currently available in Poland. These systems should be the first choice in terms of method of insulin therapy in the paediatric population. They can be implemented at any stage of diabetes management. These recommendations are based on scientific evidence and experts' experience. They include principles for the initiation, optimisation, and ongoing management of HCL therapy, as well as the required HCL-related education.
Keywords
diabetes mellitus, hybrid closed loop, automated insulin delivery systems, insulin therapy, continuous glucose monitoring
Integrated with
